He also serves as Vice-Chair for Colorectal Cancer Research for the NRG Cooperative Group
Qinglu Wang, [email protected] This article was submitted to Inflammation, a section of the journal Frontiers in Immunology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
doi: 10.1038/mp.2010.136
GHK suppressed RNA production in 70% of 54 human genes overexpressed in patients with an aggressive metastatic form of colon cancer
Moreover, targeted drug development against RCD pathways has made significant progress
[DOI] [PubMed] [Google Scholar] 188.Pedersen M.B., Hansen J.C., Mulvad G., Pedersen H.S., Gregersen M., Danscher G